Prescription drug claim denials by U.S. insurers rose 25% from 2016-2023, according to a new analysis of more than 4B medical ...

Once a key figure in Trump’s cost-cutting initiatives, Musk fell out with the president after criticizing a major ...

The lease agreement with CoreWeave de-risks Applied Digital’s business due to its 15-year period. Read why I’m reiterating my ...

AMLP offers an 8% yield, steady dividend growth, and exposure to strong energy infrastructure trends with rate-cut upside.

Goldman Sachs BDC struggles with declining earnings and NAV. Learn why I recommend holding despite yield and discount. Click ...

Nvidia leads the AI ecosystem with unmatched dominance across hardware, software, and systems, fueling strong growth. See why ...

Real money supply decline hints at tighter monetary conditions. Check out how this impacts housing, manufacturing, jobs, and ...

SGDM offers fundamentals-based gold miner exposure but lags the S&P 500 on key metrics and risk-adjusted returns. Find out ...

Holdings has accelerated revenue growth and expanded gross margins. Read what supports a compelling long-term investment ...

Teradyne leverages a duopoly in automated test systems, benefiting from strong chipmaker ties. Click here to read why TER ...

Long-term oil demand growth and Schlumberger's AI-driven digital initiatives provide powerful tailwinds for sustained ...

Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.